Coronary artery disease in chronic kidney disease patients: Assessing the evidence for diagnosis, screening and revascularization

Canadian Journal of Cardiology

Volumn 20, Issue 8, 2004, Pages 807-813

  Saw, Jacqueline ^a   Levin, Adeera ^b   Gin, Kenneth ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Coronary disease; Diabetes mellitus; Diagnosis; Kidney; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; NORTH AMERICA; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; REVIEW; SCREENING TEST; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; HEART MUSCLE REVASCULARIZATION; METHODOLOGY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; RISK FACTOR;

CLINICAL TRIALS; CORONARY DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; RENAL DIALYSIS; RISK FACTORS;

EID: 3242807545     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. US Renal Data System: USRDS 2000 Annual Report. Bethesda: National Institute of Diabetes and Digestive and Kidney Disease, 2000.
2. Canadian Organ Replacement Register (CORR). Preliminary report for dialysis and transplantation 2002. http://secure.cihi.ca/cihiweb/en/downloads/reports_corr2002prelim-e.pdf (Version current at June 8, 2004).
3. Staffeld CG, Pastan SO. Cardiac disease in patients with end-stage renal disease. Cardiol Clin 1995;13:209-23.
4. Eknoyan G, Levin NW K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 2):S1-246.
5. Zanchetti A, Stella A. Cardiovascular disease and the kidney: An epidemiologic overview. J Cardiovasc Pharm 1999;33(Suppl 1):S1-6.
6. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy: Prevalence, associations and prognosis. Kidney Int 1995;47:186-92.
7. Murphy SW, Foley RN, Parfrey PS. Screening, and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl 3):S184-99.
8. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-15.
9. Appel G. Lipid abnormities in renal disease. Kidney Int 1991;39:169-83.
10. De Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996;7:2044-54.
11. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascuIar evaluation for noncardiac surgery - Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67.
12. Kasiske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: Clinical practice guidelines developed by the patient care education committee of The American Society of Transplant Physicians. J Am Soc Nephrol 1995;6:1-34.
13. Le A, Wilson R, Douek K, et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994;24:65-71.
14. Manske C, Thomas W, Wang Y, Wilson R. Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993;44:617-21.
15. Philipson JD, Carpenter BJ, Itzkoff J, et al. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986;81:6 30-4.
16. Morrow CE, Schwartz JS, Sutherland DE, et al. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Med 1983; 146:3 31-5.
17. Brown JH, Vites NP, Testa HJ, et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dialysis Transplant 1993;8:433-7.
18. Brown KA, Rimmer J, Haisch C. Non-invasive risk stratification of diabetic and non-diabetic uremic renal allograft candidates using dipyridamole thallium 201 imaging and radionucleotide ventriculography. Am J Cardiol 1989;64:1017-21.
19. Camp A, Garvin P, Hoff J, Marsh J, Byers S, Chairman B. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990;65:1459-63.
20. Marwick TH, Steinmuller DR, Underwood DA, et al. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation 1990;49:100-3.
21. Boudreau RJ, Strony JT, duCret RP, et al. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: Comparison of oral and intravenous dipyridamole administration. Radiology 1990;175:103-5.
22. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R. Predictive value of thallium-201 dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 1991;36:192-202.
23. Vandenberg, BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezad K. evaluation of diabetic patients for renal and pancreas, transplantation. Transplantation 1996;9:1230-5.
24. Dahan M, Viron BM, Faraggi M, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 1998;54:255-62.
25. Fuster D, Magrina J, Ricart MJ, et al. Noninvasive assessment of cardiac risk in type I diabetic patients being evaluated for combined pancreas-kidney transplantation using dipyridamole-MIBI perfusion tomographic scintigraphy. Transpl Int 2000;12:327-32.
26. Reis G, Marcovitz PA, Lechtman AB, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995;75:707-10.
27. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996;77:175-9.
28. Marwick TH, Lauer MS, Nally J, Braun W. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 1998;244:155-61.
29. Herzog CA, Marwich TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999;33:1080-90.
30. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
31. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83
32. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-3.
33. Goodman WG, Salusky IB. Non-invasive assessments of cardiovascular disease in patients with renal failure. Curr Opin Nephrol Hypertens 2001;10:365-9.
34. Castelli P, Condemi AM, Munari M. Immediate and long-term results of coronary revascularization in patients undergoing chronic hemodialysis. Eur J Cardiothorac Surg, 1999; 15:51-4.
35. Ahmed WH, Pashos CL, Ayanian JZ, et al. Thirty-day and 1-year mortality in hemodialysis patients undergoing coronary revascularization: Results from a national cohort. Circulation 1995;92(Suppl):1-75.
36. De Meyer M, Wyns W, Khoury G, et al. Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991;36:147-51.
37. The Society of Thoracic Surgeons (STS). STS National Database Fall 2000 Executive Summary. http://www.ctsnet.org/doc/5456 (Version current at June 8, 2004).
38. Deutsch E, Bernstein RC, Addonizio VP, et al. Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med 1989; 110:369-72.
39. Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991;66:45-53
40. Manske CL, Nelluri S, Thomas W, Shumway SJ. Outcome of coronary artery bypass surgery in diabetic transplant candidates. Clin Transplant 1998;12:73-9.
41. Reusser L, Osborn L, White H, Sexson R, Crawford M. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994;73:965-7.
42. Kahn J, Rutherford B, McConahay D, Johnson W, Giorgi L, Hartzler G. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-9.
43. Rinehart A, Herzog C, Collins A, Flack J, Ma J, Opsahl J. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995;25:281-90.
44. Ahmed W, Shubrooks S, Gibson C, Baim D, Bittl J. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994;128:252-5.
45. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int 1999;56:324-32.
46. Ellis SG, Whitlow PL, Guetta V, et al. A highly significant 40% reduction in ischemic complications of percutaneous coronary intervention in 1995: Beginning of a new era? J Am Coll Cardiol 1996;27:253a. (Abst)
47. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. A generalized model of restenosis following conventional balloon angioplasty, stenting, and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
48. Le Feuvre C, Dambrin G, Helft G, et al. Clinical outcome following coronary angioplasty in dialysis patients: A case-control study in the era of coronary stenting. Heart 2001;85:556-60.
49. Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000;86:485-9.
50. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutineous coronary interventions. J Am Coll Cardiol 2002;39:1113-9.
51. Agirbasli M, Weintraub WS, Chang GL, et al. Outcome of coronary revascularization in patients on renal dialysis. Am J Cardiol 2000;86:395-9.
52. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207-11.